Clinical Trial to Examine Creatine as Parkinson's Treat


HealthDay - THURSDAY, March 22 (HealthDay News) -- A large-scale clinical
trial to determine whether the nutritional supplement creatine can slow
the progression of Parkinson's disease is expected to be launched Thursday
by the U.S. National Institute of Neurological Disorders and Stroke, part
of the National Institutes of Health (NIH).

Read more...